UC Candidate Therapy PL-8177 Shows Successful Delivery to Lower GI Tract
News
Use of an oral, delayed-release formulation of the ulcerative colitis treatment candidate PL-8177 led to targeted delivery to the lower gastrointestinal tract and was well-tolerated, according to top-line results of ... Read more